CAIROLI, ROBERTO

CAIROLI, ROBERTO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 318 (tempo di esecuzione: 0.041 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda 01 - Articolo su rivista 2024 Cairoli, Roberto +
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia 01 - Articolo su rivista 2024 Zappaterra, ARapella, AGambacorti-Passerini,CCairoli,R +
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients 01 - Articolo su rivista 2024 Zappaterra, AriannaCivettini, IvanPierini, SilviaGambacorti-Passerini, CarloCairoli, Roberto +
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial 01 - Articolo su rivista 2024 Cairoli, Roberto +
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 01 - Articolo su rivista 2024 Cavazza, GabrieleDi Gennaro, ElisaPeracchi, FrancescoMonti, BiancaCorti, NicolòCairoli, RobertoPuoti, Massimo +
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study 01 - Articolo su rivista 2024 Antolini, LauraMantegazza, RaffaeleCairoli, RobertoGambacorti Passerini, Carlo +
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy 01 - Articolo su rivista 2024 Cairoli, Roberto +
Fasting and Diet: Overview in Chronic Lymphocytic Leukemia 01 - Articolo su rivista 2024 Cairoli, Roberto +
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 01 - Articolo su rivista 2024 Cairoli, Roberto +
Hypoplasia of the Spleen: Rare and Puzzling 01 - Articolo su rivista 2024 Cairoli R. +
Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation 01 - Articolo su rivista 2024 Milano A.Cairoli R. +
Lymphoma’s last therapeutic option: Freeze it! 01 - Articolo su rivista 2024 Bassi, GFerrari, MBCairoli, R +
Myeloma’s multiple morphologies 01 - Articolo su rivista 2024 Cairoli, R +
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial 01 - Articolo su rivista 2024 Cairoli R. +
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial 01 - Articolo su rivista 2024 Cairoli R. +
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 01 - Articolo su rivista 2023 Cairoli, Roberto +
Assessing eligibility for treatment in acute myeloid leukemia in 2023 01 - Articolo su rivista 2023 Cairoli, Roberto +
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 01 - Articolo su rivista 2023 Cairoli R +
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 01 - Articolo su rivista 2023 Cairoli, R +
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy 01 - Articolo su rivista 2023 Cairoli R +